Arkansas Mother Alleged Zofran (ondansetron) Caused Son’s Severe Birth Defects

A new Zofran (ondansetron) lawsuit has been filed against GlaxoSmithKline (“GSK”) by an Arkansas mother alleging that the drug caused her son’s cleft lip and subsequent developmental delays, conditions he still suffers from three years later. The Arkansas mother had no idea that taking popular anti-nausea drug Zofran (ondansetron) in 2011 to combat morning sickness would cause such severe and permanent complications to her child. She alleges that GSK negligently promoted Zofran (ondansetron) “off-label,” or for a use not approved by the FDA, as the drug had never been tested to be safe or effective for use by pregnant women. Like so many other parents who were wronged by GSK’s alleged misrepresentations of Zofran (ondansetron), had the parents of the boy been aware of the adverse side effects, they would have avoided the drug completely.

Real Time Analytics